Candriam Luxembourg S.C.A. »

Maze Therapeatics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.3M 278k 29.85

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Alphabet Cap Stk Cl C (GOOG)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Arch Venture Corp
Deep Track Capital
Henderson Group
Paradigm Biocapital Advisors
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Vanguard Capital Management
Alphabet
Logos Global Management
General Catalyst Group Management
TRV GP V

View all funds holding Maze Therapeatics